Key result
LAD culprit lesions linked to ~57% higher 30-day mortality in very elderly STEMI patients.
Why the study?
LAD involvement predicts adverse outcomes in the general STEMI population, but data on its impact on 30-day mortality in very elderly patients (aged ≥85 years) are limited.
Does LAD culprit lesion affect 30-day mortality in very elderly STEMI patients undergoing PCI?
Cohort (n=586)
Yes
Does LAD culprit lesion affect 30-day mortality in very elderly STEMI patients undergoing PCI?
Effect estimate: HR 1.57 (95% CI 1.06-2.33)
p-value: p=0.024
In very elderly STEMI patients (≥85 years), LAD culprit lesions are associated with a significantly higher 30-day mortality compared to non-LAD lesions.
Warrants closer monitoring after LAD STEMI; leaves open whether this mortality risk is modifiable in prospective trials.
AIMS: ST-elevation myocardial infarction (STEMI) in very elderly patients (≥85 years) poses a major clinical challenge due to frailty and comorbidities. In the general population, left anterior descending (LAD) artery involvement predicts adverse outcomes, but data in the very elderly are limited. We aimed to evaluate the impact of LAD culprit lesions on 30-day mortality in this population. METHODS: In this multicenter registry (six Italian Hub hospitals, 2010-2023), 586 consecutive STEMI patients aged ≥85 years undergoing coronary angiography and percutaneous coronary intervention (PCI) were retrospectively analyzed. Patients were stratified by culprit vessel: LAD (n = 288) vs. non-LAD (n = 298). Demographic, clinical, procedural characteristics, and 30-day outcomes, including mortality and major adverse cardiovascular events, were collected. Multivariable analysis identified independent predictors of mortality. RESULTS: Baseline differences included prior myocardial infarction (MI) (9.4% vs. 18.5%, P < 0.01), prior CABG (0.3% vs. 4.7%, P < 0.01), and dyslipidemia (35.4% vs. 45.6%, P = 0.02), less frequent in LAD STEMI. Single-vessel disease was more common in LAD STEMI (42.0% vs. 31.5%, P = 0.01). Overall, 30-day mortality was 19.3% (113/586), higher in the LAD group [hazard ratio (HR) 1.57; 95% confidence interval (CI) 1.06-2.33; P = 0.024]. In LAD STEMI, cardiogenic shock at presentation was the strongest independent predictor of death (HR 6.10; 95% CI 3.70-10.35; P = 0.01), while dyslipidemia was associated with lower mortality (HR 0.51; 95% CI 0.28-0.92; P = 0.03). CONCLUSIONS: In very elderly STEMI patients, LAD culprit lesions are associated with higher short-term mortality. Cardiogenic shock at presentation and absence of dyslipidemia identify a high-risk subgroup, emphasizing the need for tailored risk stratification and careful procedural planning in this vulnerable population.
No takes yet. Share an insight, caveat, or question.
Agbariah et al. (2026) conducted a cohort in ST-elevation myocardial infarction (STEMI) (n=586). Left anterior descending (LAD) culprit lesion vs. Non-LAD culprit lesion was evaluated on 30-day mortality (HR 1.57, 95% CI 1.06-2.33, p=0.024). In very elderly STEMI patients, a left anterior descending (LAD) culprit lesion was associated with higher 30-day mortality compared to non-LAD lesions (HR 1.57; 95% CI 1.06-2.33; P=0.024).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: